Table of Contents Author Guidelines Submit a Manuscript
Journal of Lipids
Volume 2015, Article ID 518654, 5 pages
http://dx.doi.org/10.1155/2015/518654
Research Article

Elevated Phospholipid Transfer Protein in Subjects with Multiple Sclerosis

BVBiomed Ltd., Oregon Bioscience Incubator, 4640 SW Macadam Avenue No. 200, Portland, OR 97239, USA

Received 24 June 2015; Revised 17 July 2015; Accepted 30 July 2015

Academic Editor: Gerhard M. Kostner

Copyright © 2015 Roy A. Garvin. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. A. Garvin and A. Fleck, “Plasma protein anomally in multiple sclerosis,” in Proceedings of the Biochemical Society Annual Meeting, 1992.
  2. F. C. Westall, A. Hawkins, G. W. Ellison, and L. W. Myers, “Abnormal glutamic acid metabolism in multiple sclerosis,” Journal of the Neurological Sciences, vol. 47, no. 3, pp. 353–364, 1980. View at Publisher · View at Google Scholar · View at Scopus
  3. J.-Y. Wu, K. M. A. Welch, and C. C. Duncan, “Abnormal protein patterns in multiple sclerosis,” Neurochemical Research, vol. 4, no. 6, pp. 811–820, 1979. View at Publisher · View at Google Scholar · View at Scopus
  4. T. T. Wheeler, T. W. Jordan, and H. C. Ford, “Double-label two-dimensional electrophoresis of serum and plasma proteins from patients with multiple sclerosis,” Journal of the Neurological Sciences, vol. 78, no. 1, pp. 87–92, 1987. View at Publisher · View at Google Scholar · View at Scopus
  5. J. J. Albers, S. M. Marcovnia, and R. H. Christenson, “Lecithin cholesterol acyltransferase in human cerebrospinal fluid: reduced level in patients with multiple sclerosis and evidence of direct synthesis in the brain,” International Journal of Clinical & Laboratory Research, vol. 22, no. 1–4, pp. 169–172, 1992. View at Publisher · View at Google Scholar · View at Scopus
  6. R. Segura and X. Navarro, “Plasma lipids and their fatty acid composition in multiple sclerosis,” Acta Neurologica Scandinavica, vol. 78, no. 2, pp. 152–157, 1988. View at Publisher · View at Google Scholar · View at Scopus
  7. D. Bates, “Lipids and multiple sclerosis,” Biochemical Society Transactions, vol. 17, no. 2, pp. 289–291, 1989. View at Google Scholar · View at Scopus
  8. S. C. Cunnane, S.-Y. Ho, P. Dore-Duffy, K. R. Ells, and D. F. Horrobin, “Essential fatty acid and lipid profiles in plasma and erythrocytes in patients with multiple sclerosis,” The American Journal of Clinical Nutrition, vol. 50, no. 4, pp. 801–806, 1989. View at Google Scholar · View at Scopus
  9. H. C. Ford, “Abnormalities of serum and plasma components in patients with multiple sclerosis,” Clinical Biochemistry, vol. 18, no. 1, pp. 3–13, 1985. View at Publisher · View at Google Scholar · View at Scopus
  10. C. M. Deber and S. J. Reynolds, “Central nervous system myelin: structure, function, and pathology,” Clinical Biochemistry, vol. 24, no. 2, pp. 113–134, 1991. View at Publisher · View at Google Scholar · View at Scopus
  11. J. J. Albers, J. H. Tollefson, C. H. Chen, and A. Steinmetz, “Isolation and characterization of human plasma lipid transfer proteins,” Arteriosclerosis, vol. 4, no. 1, pp. 49–58, 1984. View at Publisher · View at Google Scholar · View at Scopus
  12. J. J. Albers, J. H. Tollefson, G. Wolfbauer, and R. E. Albright Jr., “Cholesteryl ester transfer protein in human brain,” International Journal of Clinical & Laboratory Research, vol. 21, no. 2–4, pp. 264–266, 1992. View at Publisher · View at Google Scholar · View at Scopus
  13. S. Vuletic, L.-W. Jin, S. M. Marcovina, E. R. Peskind, T. Möller, and J. J. Albers, “Widespread distribution of PLTP in human CNS: evidence for PLTP synthesis by glia and neurons, and increased levels in Alzheimer's disease,” Journal of Lipid Research, vol. 44, no. 6, pp. 1113–1123, 2003. View at Publisher · View at Google Scholar · View at Scopus
  14. J. F. Kurtzke, “Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS),” Neurology, vol. 33, no. 11, pp. 1444–1452, 1983. View at Publisher · View at Google Scholar · View at Scopus
  15. J. H. Tollefson and J. J. Albers, “Isolation, characterization, and assay of plasma lipid transfer proteins,” Methods in Enzymology, vol. 129, pp. 797–816, 1986. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Burstein, H. R. Scholnick, and R. Morfin, “Rapid method for the isolation of lipoproteins from human serum by precipitation with polyanions,” Journal of Lipid Research, vol. 11, no. 6, pp. 583–595, 1970. View at Google Scholar · View at Scopus
  17. T. Mahmood and P.-C. Yang, “Western blot: technique, theory, and trouble shooting,” North American Journal of Medical Sciences, vol. 4, no. 9, pp. 429–434, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. F. Sanger and A. R. Coulson, “A rapid method for determining sequences in DNA by primed synthesis with DNA polymerase,” Journal of Molecular Biology, vol. 94, no. 3, pp. 441–448, 1975. View at Publisher · View at Google Scholar · View at Scopus
  19. F. Sanger, S. Nicklen, and A. R. Coulson, “DNA sequencing with chain-terminating inhibitors,” Proceedings of the National Academy of Sciences of the United States of America, vol. 74, no. 12, pp. 5463–5467, 1977. View at Publisher · View at Google Scholar · View at Scopus
  20. S. Vuletic, H. Kennedy, J. J. Albers et al., “Cerebrospinal fluid apolipoprotein e and phospholipid transfer protein activity are reduced in multiple sclerosis; relationships with the brain MRI and CSF lipid variables,” Multiple Sclerosis and Related Disorders, vol. 3, no. 4, pp. 533–541, 2014. View at Publisher · View at Google Scholar · View at Scopus
  21. C. van de Kraats, J. Killestein, V. Popescu et al., “Oxysterols and cholesterol precursors correlate to magnetic resonance imaging measures of neurodegeneration in multiple sclerosis,” Multiple Sclerosis, vol. 20, no. 4, pp. 412–417, 2014. View at Publisher · View at Google Scholar · View at Scopus
  22. C. E. Teunissen, C. D. Dijkstra, C. H. Polman, E. L. J. Hoogervorst, K. von Bergmann, and D. Lütjohann, “Decreased levels of the brain specific 24S-hydroxycholesterol and cholesterol precursors in serum of multiple sclerosis patients,” Neuroscience Letters, vol. 347, no. 3, pp. 159–162, 2003. View at Publisher · View at Google Scholar · View at Scopus
  23. M. Y. Alenezi, M. Marcil, D. Blank, M. Sherman, and J. Genest Jr., “Is the decreased high-density lipoprotein cholesterol in the metabolic syndrome due to cellular lipid efflux defect?” Journal of Clinical Endocrinology and Metabolism, vol. 89, no. 2, pp. 761–764, 2004. View at Publisher · View at Google Scholar · View at Scopus
  24. X. Chen, A. Sun, A. Mansoor et al., “Plasma PLTP activity is inversely associated with HDL-C levels,” Nutrition & Metabolism, vol. 6, article 49, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. M. C. Cheung and J. J. Albers, “Active plasma phospholipid transfer protein is associated with apoA-I- but not apoE-containing lipoproteins,” Journal of Lipid Research, vol. 47, no. 6, pp. 1315–1321, 2006. View at Publisher · View at Google Scholar · View at Scopus
  26. M. C. Cheung, T. Vaisar, X. Han, J. W. Heinecke, and J. J. Albers, “Phospholipid transfer protein in human plasma associates with proteins linked to immunity and inflammation,” Biochemistry, vol. 49, no. 34, pp. 7314–7322, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. R. A. Levy, A. E. Gharavi, L. R. Sammaritano, L. Habina, and M. D. Lockshin, “Fatty acid chain is a critical epitope for antiphospholipid antibody,” Journal of Clinical Immunology, vol. 10, no. 3, pp. 141–145, 1990. View at Publisher · View at Google Scholar · View at Scopus
  28. J. Huuskonen, V. M. Olkkonen, M. Jauhiainen, and C. Ehnholm, “The impact of phospholipid transfer protein (PLTP) on HDL metabolism,” Atherosclerosis, vol. 155, no. 2, pp. 269–281, 2001. View at Publisher · View at Google Scholar · View at Scopus
  29. A. P. C. Manavalan, A. Kober, J. Metso et al., “Phospholipid transfer protein is expressed in cerebrovascular endothelial cells and involved in high density lipoprotein biogenesis and remodeling at the blood-brain barrier,” The Journal of Biological Chemistry, vol. 289, no. 8, pp. 4683–4698, 2014. View at Publisher · View at Google Scholar · View at Scopus